Navigation Links
Researchers discover Achilles' heel in lethal form of prostate cancer
Date:11/16/2011

NEW YORK -- An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.

In today's issue of Cancer Discovery, the researchers report that the investigational drug had a dramatic response in animal models of neuroendocrine prostate cancer, and so provides the first hope of an effective human therapy for this lethal cancer. While fewer than 2 percent of prostate tumors in men are initially classified as neuroendocrine, many common adenocarcinoma prostate cancers change their biology during hormone therapy and morph into this aggressive subtype.

The study is the largest in-depth analysis of neuroendocrine prostate cancer yet undertaken, and the findings "are very exciting, because our bench-to-bedside approach identified a new molecular target for a subtype of prostate cancer for which a drug is now available," says the study's senior investigator, Dr. Mark A. Rubin, a professor of pathology and laboratory medicine at Weill Cornell Medical College and a pathologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

The finding is especially important because many men are now being treated with new, highly potent androgen suppression therapy, which these researchers believe will significantly increase the risk of future development of neuroendocrine tumors. Androgen is the fuel that feeds adenocarcinoma prostate cancers -- the most common kind of prostate cancer -- and androgen suppression therapy effectively destroys cancer cells that depend on this hormone. But the treatment does not touch neuroendocrine cells that may have been part of the tumor mix, and those untreatable cells now have room to grow and spread, the researchers say.

Although most of the approximately 30,0
'/>"/>

Contact: John Rodgers
jdr2001@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Jackson Laboratory researchers uncover steps in synapse building, pruning
2. UCLA stem cell researchers uncover mechanism that regulates human pluripotent stem cell metabolism
3. Ben-Gurion University of the Negev researchers achieve male fertility breakthrough
4. Canadian researchers find potential new leukemia treatment with old antibiotic drug
5. FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover
6. Jefferson researchers study outcomes of carotid artery stenting following prior carotid procedure
7. Researchers gain insight into 100-year-old Haber-Bbosch process
8. New funding will help researchers learn how preschoolers move, battle early child obesity
9. Pitt researchers using mathematics to target Parkinsons disease symptoms
10. Moffitt Cancer Center researchers unravel biochemical factor important in tumor metastasis
11. Lose the fat and improve the gums, CWRU dental researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, the ... home of Zerorez Indianapolis, which plans to expand across the state. , Ray Kennedy, ... second full year in business and we should double our first year’s revenue. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... Group, which Breckheimer oversees. In her role, Powers is responsible for driving growth ... the announcement, Breckheimer commented, “Gina’s track record as an effective leader within the ...
(Date:7/28/2015)... ... July 29, 2015 , ... Talking About Your Product Pipeline:, How FDA ... – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , When a company has a product ... say about it is tightly regulated by the FDA. , At the same time, ...
(Date:7/28/2015)... ... , ... Every July, since 2007, about 25 pediatric pulmonary hypertension (PH) patients ... television. They go to summer camp. , PH is incurable and life threatening, as ... pushes hard to get blood through arteries in the lungs narrowed by the disease. ...
Breaking Medicine News(10 mins):Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
... cholesterol level in blood.,High level of cholesterol, which is ... can lead to serious health risks. ,// ,Researchers ... examined 199 healthy middle-aged men and women to know ... can increase cholesterol and heighten cardiovascular risk, reports Newswise ...
... of bird flu, even as the government has given approval ... ,The latest outbreaks of the deadly H5N1 strain of ... southwestern province of Yunnan and the northwestern region of Ningxia, ... birds died in Yunnan's Chuxiong district Thursday, and 230 died ...
... is planning expansion of its super-speciality hospital chain with ... Kolkata and Bangalore.// ,"We have embarked on the ... Delhi) which would be ready by 2007-end. We also ... the chain's vice president, told IANS., ,Unlike the ...
... more than 1,200 children, whose organs were removed after death ... average of about ?2,900 in a compensation deal announced recently ... the apex body had fought the cases involving organ-retention ... to a total figure of around ?3.6 million for the ...
... people could be putting their health at risk by ... and other health professionals.// ,The survey of more ... Health Professions Council (HPC), found that about 81% of ... professional were oblivious to whether they were properly qualified ...
... juice has anti-bacterial properties? It has now been found ... compounds that can help preserve dental health by prevention ... University of Rochester Medical Center have been credited with ... acts just similar to a Teflon sheath, commonly used ...
Cached Medicine News:Health News:Wockhardt Group Plans Hospital In Delhi By End-2007 2Health News:Organ Scandals Compensation And The Aftermath 2Health News:Credentials Of Specialists Need To Be Checked 2Health News:Cranberry juice to Prevent Dental Decay 2
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Craniomaxillofacial Implants Market ... and Forecast 2014 - 2022" report to ... craniomaxillofacial implants market studies the current and future ... rapidly gaining popularity in the global market due ...
(Date:7/28/2015)... 28, 2015 The Physician-Patient Alliance for Health ... campaign, " Surviving Your Hospital Stay ." ... deserve! None of these patients went home from hospital," ... Director, PPAHS) referring to the patient stories ... Coalition to Promote Continuous Monitoring of Patients on Opioids ...
(Date:7/28/2015)... --  Vincari , known for their Lightspeed Valet ... John O,Neil as their Executive Vice President of ... of diverse and progressive experience within the healthcare industry ... with Vincari,s CMO, Dr. Lucian Newman,s experience ... challenges both hospitals and surgeons face, including the need ...
Breaking Medicine Technology:Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... NEW YORK, Oct. 6, 2011 ... research report is available in its ... Therapeutics Market to 2017 - Patent ... Negatively Impact Dyslipidemia Market Value ...
... Calif. and BARCELONA, Spain, Oct. 6, 2011 ... and Grupo Ferrer International, S.A., announced today that they ...  ADASUVE is Alexza,s lead program, based on the company,s ... is a leading pharmaceutical company in Europe with extensive ...
Cached Medicine Technology:Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 2Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 3Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 4Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 5Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 6Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 7Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 8Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 9Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 10Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 11Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 12Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 13Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 14Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 15Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 2Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 3Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 4Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 5Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 6Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: